buthionine sulfoximine has been researched along with aldosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galigniana, MD; Piwien-Pilipuk, G | 1 |
| Abukhalaf, IK; Bayorh, MA; Eatman, D; Ganafa, AA; Silvestrov, N; Socci, RR | 1 |
2 other study(ies) available for buthionine sulfoximine and aldosterone
| Article | Year |
|---|---|
Oxidative stress induced by L-buthionine-(S,R)-sulfoximine, a selective inhibitor of glutathione metabolism, abrogates mouse kidney mineralocorticoid receptor function.
Topics: Aldosterone; Animals; Antimetabolites; Buthionine Sulfoximine; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Humans; Kidney; Mice; Mineralocorticoids; Oxidation-Reduction; Oxidative Stress; Receptors, Mineralocorticoid; Steroids; Sulfhydryl Compounds; Sulfhydryl Reagents | 2000 |
Effect of losartan on oxidative stress-induced hypertension in Sprague-Dawley rats.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Buthionine Sulfoximine; Cyclic AMP; Cyclic GMP; Dinoprost; Disease Models, Animal; Enzyme Inhibitors; Epoprostenol; F2-Isoprostanes; Glutathione; Heart Rate; Hypertension; Kidney; Losartan; Male; Models, Cardiovascular; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides; Thromboxane A2; Treatment Outcome | 2003 |